Sep 29, 2026 07:03AM

Sep 29, 2026 07:00AM

Mar 18, 2026 06:33AM

Mar 17, 2026 08:30AM

Mar 17, 2026 08:30AM

Dec 16, 2025 03:57AM

Dec 15, 2025 07:30PM Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease

Oct 8, 2025 12:58PM

Aug 8, 2025 12:20PM

Jul 17, 2025 07:02AM

Jul 17, 2025 07:00AM

Jun 17, 2025 07:02AM

Jun 17, 2025 07:00AM

Mar 17, 2025 05:18AM BTIG Reiterates Buy Rating on Aldeyra Therapeutics (ALDX)

Dec 16, 2024 06:47AM

Nov 18, 2024 07:04AM

Nov 18, 2024 07:00AM

Oct 3, 2024 07:00AM

Oct 3, 2024 07:00AM

Feb 27, 2024 07:00AM

Oct 16, 2023 08:16AM Aldeyra Therapeutics (ALDX) received minutes from a late-cycle review meeting with FDA for reproxalap

Aug 8, 2023 04:01PM

Jun 15, 2023 07:02AM

Jun 15, 2023 07:00AM

May 4, 2023 07:00AM

Mar 9, 2023 07:00AM

Mar 2, 2023 07:00AM

Mar 2, 2023 07:00AM FDA Accepts for Priority Review ADX-2191 New Drug Application for the Treatment of Primary Vitreoretinal Lymphoma

Feb 7, 2023 07:01AM

Feb 7, 2023 07:00AM

15,923 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All